Cytokinetics Inc (CYTK)
Debt-to-assets ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 1,401,670 | 1,436,060 | 1,523,790 | 808,082 | 824,316 | 740,614 | 779,899 | 889,815 | 1,014,780 | 1,075,960 | 771,717 | 856,253 | 841,319 | 827,539 | 564,302 | 577,062 | 533,803 | 474,112 | 232,495 | 256,582 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,401,670K
= 0.00
The debt-to-assets ratio for Cytokinetics Inc has consistently remained at 0.00 from March 31, 2020, to December 31, 2024. This indicates that the company has not taken on any debt to finance its assets during this period. A debt-to-assets ratio of 0.00 suggests that the company's assets are fully financed by its equity, which may be seen as a positive sign of financial stability and lower financial risk. However, it's important to note that a very low debt-to-assets ratio may also indicate a conservative approach to financing, potentially limiting the company's growth opportunities compared to leveraging debt for expansion or investment.
Peer comparison
Dec 31, 2024